Literature DB >> 23233050

Perillyl alcohol causes G1 arrest through p15(INK4b) and p21(WAF1/Cip1) induction.

Makoto Koyama1, Yoshihiro Sowa, Toshiaki Hitomi, Yosuke Iizumi, Motoki Watanabe, Tomoyuki Taniguchi, Masami Ichikawa, Toshiyuki Sakai.   

Abstract

The monoterpene perillyl alcohol (POH) is a naturally occurring compound derived from citrus fruits, mint and herbs. It exhibited chemotherapeutic potential against various malignant tumors in preclinical models and is currently being tested in clinical trials in patients with refractory advanced cancers. POH inhibits cellular proliferation at the G1 phase of the cell cycle in vitro. However, the molecular mechanisms responsible for this effect have not been sufficiently elucidated. Here we showed that 1.0 mM POH upregulates p15(INK4b) and p21(WAF1/Cip1), resulting in hypophosphorylation of the retinoblastoma (RB) protein and subsequent G1 arrest in human immortalized keratinocyte HaCaT cells. The induction of p15(INK4b) was mediated through its promoter, but that of p21(WAF1/Cip1) was not. The small interfering RNA (siRNA) of either p15(INK4b) or p21(WAF1/Cip1) significantly attenuated the increase in the G1 cell population caused by POH. The induction of p15(INK4b) and p21(WAF1/Cip1) and sub-sequent G1 arrest by POH was also observed in other cancer cell lines. These results suggest that the induction of p15(INK4b) as well as p21(WAF1/Cip1) is associated with the antiproliferative effect of POH.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23233050     DOI: 10.3892/or.2012.2167

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

Review 1.  Preclinical development and clinical use of perillyl alcohol for chemoprevention and cancer therapy.

Authors:  Thomas C Chen; Clovis O Da Fonseca; Axel H Schönthal
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study.

Authors:  Marcela de Oliveira Silva; Graziella Ribeiro de Sousa; Sarah Capelupe Simões; Patrícia Nicolucci; Edwin Tamashiro; Fabiano Saggioro; Ricardo Santos de Oliveira; María Sol Brassesco
Journal:  Childs Nerv Syst       Date:  2021-04-22       Impact factor: 1.475

3.  Inhibitory effect of trans-ferulic acid on proliferation and migration of human lung cancer cells accompanied with increased endogenous reactive oxygen species and β-catenin instability.

Authors:  Yao Fong; Chia-Chun Tang; Huei-Ting Hu; Hsin-Yu Fang; Bing-Hung Chen; Chang-Yi Wu; Shyng-Shiou Yuan; Hui-Min David Wang; Yen-Chun Chen; Yen-Ni Teng; Chien-Chih Chiu
Journal:  Chin Med       Date:  2016-10-01       Impact factor: 5.455

Review 4.  Essential oils and their constituents as anticancer agents: a mechanistic view.

Authors:  Nandini Gautam; Anil K Mantha; Sunil Mittal
Journal:  Biomed Res Int       Date:  2014-06-09       Impact factor: 3.411

5.  In Vivo Anti-Tumor Activity and Toxicological Evaluations of Perillaldehyde 8,9-Epoxide, a Derivative of Perillyl Alcohol.

Authors:  Luciana Nalone Andrade; Ricardo Guimarães Amaral; Grace Anne Azevedo Dória; Cecília Santos Fonseca; Tayane Kayane Mariano da Silva; Ricardo Luiz Cavalcante Albuquerque Júnior; Sara Maria Thomazzi; Lázaro Gomes do Nascimento; Adriana Andrade Carvalho; Damião Pergentino de Sousa
Journal:  Int J Mol Sci       Date:  2016-01-04       Impact factor: 5.923

Review 6.  Biochemical significance of limonene and its metabolites: future prospects for designing and developing highly potent anticancer drugs.

Authors:  Yusif M Mukhtar; Michael Adu-Frimpong; Ximing Xu; Jiangnan Yu
Journal:  Biosci Rep       Date:  2018-11-13       Impact factor: 3.840

Review 7.  The Monoterpenoid Perillyl Alcohol: Anticancer Agent and Medium to Overcome Biological Barriers.

Authors:  Thomas C Chen; Clovis O da Fonseca; Daniel Levin; Axel H Schönthal
Journal:  Pharmaceutics       Date:  2021-12-16       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.